Monopar Therapeutics
MNPR
$0.61
Share price
1.34%
Change (1 day)
-28.83%
Change (1 year)
Categories
EPS for Monopar Therapeutics (MNPR)
EPS in 2023 (TTM): -$0.77
According to Monopar Therapeutics's latest financial reports the company's current EPS (TTM) is -$0.77. In 2022 the company made an earnings per share (EPS) of -$0.83 a decrease over its 2021 EPS that were of -$0.74.
EPS history for Monopar Therapeutics from 2017 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$0.77 | -7.23% |
| 2022 | -$0.83 | 12.16% |
| 2021 | -$0.74 | 27.59% |
| 2020 | -$0.58 | 43.71% |
| 2019 | -$0.40 | 33.52% |
| 2018 | -$0.30 | -80.97% |
| 2017 | -$1.59 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | 183.12% | 🇺🇸 USA |